DianaPatriciaCastroMD

Neuromuscular Medicine

Founder and Director of Neurology & Neuromuscular and Neurology Rare Disease Center

Overview of Dr. Castro

Dr.Castro is a neurologist and neuromuscular specialist in Denton,TX . She is the founder and director of a nonprofit private practice, and a research center for neuromuscular conditions. She received her medical degree from the Universidad Javeriana, pediatric training at SUNY, child neurology and neuromuscular at UTSW. She has extensive experience with patients with SMA, DMD, MG and CIDP.

Office
2817 S Mayhill Rd
suite 115
Denton, TX 76208
Book by Phone+1(469) 778-3989

Fax+1 972-982-7610

Education & Training

University of Texas Southwestern Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2011 - 2012
University of Texas Southwestern Medical CenterFellowship, Child Neurology, 2008 - 2011
SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 2006 - 2008
Pontifical Xavierian UniversityClass of 2002

Certifications & Licensure

TX State Medical License 2012 - 2026
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Clinical Trials

Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Start of enrollment: 2012 Feb 27
Completed
Phase 2
International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
Active, not recruiting
Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Start of enrollment: 2013 Mar 26
Completed
Phase 3
A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
Terminated
Phase 3
A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA). Start of enrollment: 2015 Aug 19
Terminated
Phase 2
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2016 Jan 04
Terminated
Phase 2
A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J) Start of enrollment: 2019 Jul 18
Terminated
Join now to see all

Publications & Presentations

PubMed

95 citations
Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study.
Stephen J. Kolb, Christopher S. Coffey, Jon W. Yankey, Kristin J. Krosschell, W. David Arnold
Annals of Clinical and Translational Neurology. 2016-02-01
43 citations
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study
Edward C. Smith, Laurie S. Conklin, Eric P. Hoffman, Paula R. Clemens, Jean K. Mah
Plos Medicine. 2020-09-21
256 citations
Natural history of infantile-onset spinal muscular atrophy.
Stephen J. Kolb, Christopher S. Coffey, Jon W. Yankey, Kristin J. Krosschell, W. David Arnold
Annals of Neurology. 2017-12-01

Books/Book Chapters

Novel Challenges in Myasthenia Gravis- Tommaso Claudio Mineo MD
Chapter 12: Juvenile Myasthenia Gravis: From Diagnosis to treatment2015

Press Mentions

This New North Texas Clinic Helps People with a Rare Muscle-Wasting DiseaseMarch 25th, 2023
The Non-Profit Clinic Is the First in DFW That Specializes in the Treatment of Patients with Rare Neuromuscular DiseasesMarch 6th, 2023
Early Signs and Symptoms of SMANovember 22nd, 2022
Join now to see all